Navigation Links
Dr. Marilyn M. Li, M.D., FACMG, is the 2010 Luminex/ACMGF award recipient
Date:4/2/2010

The American College of Medical Genetics Foundation (ACMGF) has awarded Dr. Marilyn M. Li, of the Tulane Medical Center and the Tulane University School of Medicine the 2010-2011 Luminex/ACMGF Award at the ACMG 2010 Annual Clinical Genetics Meeting in Albuquerque, NM. The award includes a $100,000 grant and is aimed at the promotion of safe and effective genetic testing and services, including the development of research guidelines.

"Medical geneticists have an integral role in translating genetic research into medical services and in ensuring the safe integration of genetics into healthcare and public health. The Luminex/ACMGF Award recognizes this vital role of medical geneticists by supporting an individual in undertaking activities that promote the uppermost levels of safety and effectiveness in genetic testing and genetic services," said R. Rodney Howell, MD, FACMG, President of the ACMGF.

Dr. Li is Associate Professor of Pediatrics at the Tulane Medical Center, in New Orleans, Associate Director of the Hayward Genetics Center, Director of the Cytogenetics and Laboratory and Molecular Diagnosis Laboratory at the Tulane University School of Medicine and the Director of the Genetics/Genomics Core Laboratory of the Louisiana Cancer Research Consortium.

In response to the growing interest of applying microarray technology in cancer diagnosis, Dr. Li initiated and organized, along with Dr. Anwar Iqbal of University of Rochester Medical Center (URMC) and Dr. Charles Lee of Harvard Medical School, the Cancer Cytogenomics Microarray Consortium (CCMC). Dr. Li and her co-PI Dr. Iqbal will study the efficacy of microarray-based testing for detection of genetic aberrations in hematologic malignancies. Their goals are to develop and validate a microarray design specific for cancer diagnosis, to establish a diagnostic algorithm, and to propose practical guidelines. The results of this project will facilitate the development and utilization of microarray-based technology for high quality, reliable cancer genetic testing in CLIA certified diagnostic laboratories..


'/>"/>

Contact: Kathy Beal, MBA
kbeal@acmg.net
301-238-4582
American College of Medical Genetics
Source:Eurekalert

Related biology news :

1. AACR applauds nomination of Francis S. Collins, M.D., Ph.D., to be the new NIH director
2. Georgetown Universitys Howard J. Federoff, M.D., Ph.D. receives Bernard Sanberg Memorial Award
3. Jonathan Berg, M.D., Ph.D. awarded Richard King Trainee Award for Best in Genetics in Medicine
4. Sihoun Hahn, M.D., Ph.D., FACMG is the 2009-2010 Luminex/ACMGF Award recipient
5. David H. Ledbetter, PhD, FACMG is the 2008-2009 Luminex/ACMGF Award recipient
6. Leading conservation scientists awarded prestigious 2010 Tyler Environmental Prize
7. Ayman El-Hattab, MD is awarded the 2010 Genzyme/ACMG Foundation Genetics Fellowship
8. University of Nevada, Reno, professor receives exclusive American Fisheries Award of Excellence
9. 2010 Human Frontier Science Program awards announced
10. University of Cincinnatis William Vanooij earns first Ohio Patent Award from Ohio Academy of Science
11. Leader in genetics, Dr. David L. Rimoin, receives ACMG Foundation Lifetime Achievement Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2016)... March 31, 2016   ... or the "Company") LegacyXChange is excited to ... its soon to be launched online site for trading ... ) will also provide potential shareholders a sense ... technology to an industry that is notorious for fraud. ...
(Date:3/29/2016)... LegacyXChange, Inc. (OTC: LEGX ... Protect are pleased to announce our successful effort to ... of writing instruments, ensuring athletes signatures against counterfeiting and ... athletes on LegacyXChange will be assured of ongoing proof ... Bill Bollander , CEO states, "By inserting ...
(Date:3/22/2016)... March 22, 2016 ... Sensors Market for Consumer Industry by Type (Image, ... Application (Communication & IT, Entertainment, Home Appliances, ... Forecast to 2022", published by MarketsandMarkets, the ... to reach USD 26.76 Billion by 2022, ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young Investigator ... Members of the Class of 2016 were selected from a pool of 128 ... About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... In a ... Hospital in Denmark detail how a patient who developed lymphedema after being treated for ... The results could change the paradigm for dealing with this debilitating, frequent side effect ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... is exhibiting at the Pennsylvania Convention Center and will showcase its product’s latest ... ClinCapture will also be presenting a scientific poster on Disrupting Clinical Trials in ...
Breaking Biology Technology: